Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F30CA257677, T32GM008444
NIGMS NIH HHS
Grant: T32 GM008444
NCI NIH HHS
Grant: F30 CA257677
National Institutes of Health
Grant: 2T32GM008444-24
Medical Scientist Training Program
National Institutes of Health
Grant: 5F30CA257677-04
The oncogenic functions of Neuropilin-1 in the glioblastoma tumor microenvironment
Stony Brook University
FWCI
2.35
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals